Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleDabigatran (Pradaxa<sup>®</sup>): surgeon's friend or foe?AuthorsSyyed, N.; Ansell, M.; Sood, V.AbstractAll clinicians, whether in primary or secondary care settings, are likely to encounter patients on this new anticoagulant. Therefore, it is imperative that clinicians are aware of the risks and benefits associated with dabigatran.SubjectsANTICOAGULANTS; HEMATOLOGIC agents; CIRCULATING anticoagulants; BLOOD coagulation; PHARMACOLOGY; ARRHYTHMIA preventionPublicationBritish Dental Journal, 2014, Vol 217, Issue 11, p623ISSN0007-0610Publication typeArticleDOI10.1038/sj.bdj.2014.1051